Suppr超能文献

消旋麻黄碱的实验与临床研究

[Experimental and clinical study of d, 1-oxyphedrin].

作者信息

Güller H, Amon I, Lampe I, Paul W, Peters R

出版信息

Farmakol Toksikol. 1975 Sep-Oct;38(5):563-5.

PMID:1102329
Abstract

Comparative pharmacological and toxicological studies were carried out on animals covering the preparation d,1-oxyphedrine (myophedrine), put out in the GDR, as against the drug 1-oxyphedrine. The activity of both drugs showed no material difference. Clinical trials demonstrated good tolerance of the drug both by healthy persons and patients with its intravenous administration twice a day in amounts of 1 mg, or by mouth--3 times a day in amounts of 8--16 mg. In outpatients with anginal pains after sustained myocardial infarction and also in institutionally treated patients with myocardial infarction the activity of d,1-oxyphedrine proved to be not inferior to that of 1-oxyphedrine.

摘要

对德意志民主共和国生产的制剂消旋氧麻黄碱(美速克新命)与药物氧麻黄碱进行了动物比较药理和毒理学研究。两种药物的活性没有实质性差异。临床试验表明,健康人和患者对该药物耐受性良好,静脉注射每日两次,剂量为1毫克,或口服每日三次,剂量为8 - 16毫克。在陈旧性心肌梗死后有心绞痛的门诊患者以及住院治疗的心肌梗死患者中,消旋氧麻黄碱的活性被证明不低于氧麻黄碱。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验